929 results on '"JAKOBSEN, ANDERS"'
Search Results
2. NK cell activity and methylated HOXA9 ctDNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors
3. MindReader: Recommendation over Knowledge Graph Entities with Explicit User Ratings
4. Soluble programmed death ligand 1 as prognostic biomarker in non-small cell lung cancer patients receiving nivolumab, pembrolizumab or atezolizumab therapy
5. First experiences of a hospital-based 3D printing facility – an analytical observational study
6. ctDNA-Response evaluation criteria in solid tumors – a new measure in medical oncology
7. Analysis of HOXA9 methylated ctDNA in ovarian cancer using sense-antisense measurement
8. Performance of the EarlyCDT® Lung test in detection of lung cancer and pulmonary metastases in a high-risk cohort
9. How Diverse Are Federated Query Execution Plans Really?
10. Carboplatin re-treatment in platinum-resistant epithelial ovarian cancer patients
11. Long-Term Patient-Reported Outcomes After High-Dose Chemoradiation Therapy for Nonsurgical Management of Distal Rectal Cancer
12. Prognostic impact of early ctDNA dynamics during chemotherapy of metastatic cancer
13. ctDNA-guided adjuvant treatment after radical-intent treatment of metastatic spread from colorectal cancer—the first interim results from the OPTIMISE study
14. Improving Visualization of Intramuscular Perforator Course: Augmented Reality Headsets for DIEP Flap Breast Reconstruction
15. Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an individual participant data meta-analysis
16. Veliparib and topotecan for patients with platinum-resistant or partially platinum-sensitive relapse of epithelial ovarian cancer with BRCA negative or unknown BRCA status
17. Long-range symmetry breaking in embedded ferroelectrics
18. Decreased concentrations of intracellular signaling proteins in colon cancer patients with BRAF mutations
19. Table 5 from Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
20. Figure 4 from Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
21. Figure 3 from Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
22. Table 6 from Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
23. Figure 5 from Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
24. Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy
25. How Diverse Are Federated Query Execution Plans Really?
26. Prognostic Value of Serum NPY Hypermethylation in Neoadjuvant Chemoradiotherapy for Rectal Cancer: Secondary Analysis of a Randomized Trial
27. Experiences of precarious work among graduates in the Danish labour market
28. Precarity in Nordic working life?
29. Assessment of circulating biomarkers for detection of lung cancer in a high-risk cohort
30. Circulating tumor DNA: Response Evaluation Criteria in Solid Tumors – can we RECIST? Focus on colorectal cancer
31. The clinical importance of BRCAness in a population-based cohort of Danish epithelial ovarian cancer
32. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study
33. 524 Soluble programmed death ligand 1 as prognostic biomarker in non-small cell lung cancer receiving immune check-point inhibitors – applicability and potential caveats
34. 1013 Prognostic value of natural killer cell activity and derived neutrophils-to-lymphocytes ratio in non-small cell lung cancer patients receiving immune checkpoint inhibitors
35. OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer – a ctDNA-guided phase II randomised approach. Study protocol
36. Anal carcinoma – Survival and recurrence in a large cohort of patients treated according to Nordic guidelines
37. Long-Term Results of a Randomized Trial in Locally Advanced Rectal Cancer: No Benefit From Adding a Brachytherapy Boost
38. Curative chemoradiation for low rectal cancer::Primary clinical outcomes from a multicenter phase II trial
39. Curative chemoradiation for low rectal cancer: Primary clinical outcomes from a multicenter phase II trial.
40. Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients
41. NK cell activity and methylated HOXA9 circulating tumor DNA as prognostic biomarkers in patients with non-small cell lung cancer treated with PD-1/PD-L1 inhibitors.
42. Veliparib Monotherapy to Patients With BRCA Germ Line Mutation and Platinum-Resistant or Partially Platinum-Sensitive Relapse of Epithelial Ovarian Cancer: A Phase I/II Study
43. Multiscale 3D characterization with dark-field x-ray microscopy
44. Radiation Techniques for Increasing Local Control in the Non-Surgical Management of Rectal Cancer
45. Cell Free Methylated Tumor DNA in Bronchial Lavage as an Additional Tool for Diagnosing Lung Cancer—A Systematic Review
46. The Prognostic Importance of ctDNA in Rectal Cancer: A Critical Reappraisal
47. Prognostic Impact of Circulating Methylated Homeobox A9 DNA in Patients Undergoing Treatment for Recurrent Ovarian Cancer
48. Reporting on circulating tumor DNA monitoring in metastatic cancer—From clinical validity to clinical utility
49. Radiation Dose-Response Model for Locally Advanced Rectal Cancer After Preoperative Chemoradiation Therapy
50. sj-pdf-1-imr-10.1177_03000605221108924 - Supplemental material for Natural killer cell activity as a biomarker for the diagnosis of lung cancer in high-risk patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.